222 related articles for article (PubMed ID: 12378598)
21. Apoptosis and proliferation of human hepatocellular carcinoma.
Hino N; Higashi T; Nouso K; Nakatsukasa H; Tsuji T
Liver; 1996 Apr; 16(2):123-9. PubMed ID: 8740846
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of bcl-2 protects hepatoma cell line HCC-9204 from ethanol-induced apoptosis.
Yang L; Si X; Wang W
Chin Med J (Engl); 2002 Jan; 115(1):8-11. PubMed ID: 11930666
[TBL] [Abstract][Full Text] [Related]
23. X-linked inhibitor of apoptosis (XIAP) and XIAP-associated factor-1 expressions and their relationship to apoptosis in human hepatocellular carcinoma and non-cancerous liver tissues.
Sakemi R; Yano H; Ogasawara S; Akiba J; Nakashima O; Fukahori S; Sata M; Kojiro M
Oncol Rep; 2007 Jul; 18(1):65-70. PubMed ID: 17549347
[TBL] [Abstract][Full Text] [Related]
24. Fine needle aspiration biopsy of hepatocellular carcinoma. Some unusual features.
Wee A; Nilsson B; Chan-Wilde C; Yap I
Acta Cytol; 1991; 35(6):661-70. PubMed ID: 1659093
[TBL] [Abstract][Full Text] [Related]
25. Expression of transforming growth factor-beta 1 in hepatocellular carcinoma in comparison with the non-tumor tissue.
Idobe Y; Murawaki Y; Kitamura Y; Kawasaki H
Hepatogastroenterology; 2003; 50(49):54-9. PubMed ID: 12629989
[TBL] [Abstract][Full Text] [Related]
26. Apoptosis and cell proliferation correlated with tumor grade in patients with lung adenocarcinoma.
Kalogeraki A; Tzardi M; Zoras O; Giannikaki E; Papadakis M; Tamiolakis D; Petraki PE; Diamantis A; Siafakas N; Stathopoulos E
In Vivo; 2010; 24(5):667-70. PubMed ID: 20952731
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma.
Tannapfel A; Geissler F; Köckerling F; Katalinic A; Hauss J; Wittekind C
J Pathol; 1999 Mar; 187(4):439-45. PubMed ID: 10398104
[TBL] [Abstract][Full Text] [Related]
28. Determination of S-phase cells by in situ hybridization for histone H3 mRNA in hepatocellular carcinoma: correlation with histologic grade and other cell proliferative markers.
Nagao T; Ishida Y; Kondo Y
Mod Pathol; 1996 Feb; 9(2):99-104. PubMed ID: 8657727
[TBL] [Abstract][Full Text] [Related]
29. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma.
Nouso K; Urabe Y; Higashi T; Nakatsukasa H; Hino N; Ashida K; Kinugasa N; Yoshida K; Uematsu S; Tsuji T
Cancer; 1996 Jul; 78(2):232-36. PubMed ID: 8673997
[TBL] [Abstract][Full Text] [Related]
30. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma.
Zhang H; Ozaki I; Mizuta T; Hamajima H; Yasutake T; Eguchi Y; Ideguchi H; Yamamoto K; Matsuhashi S
Oncogene; 2006 Oct; 25(45):6101-12. PubMed ID: 16682950
[TBL] [Abstract][Full Text] [Related]
31. COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis.
Ma NF; Lau SH; Hu L; Xie D; Wu J; Yang J; Wang Y; Wu MC; Fung J; Bai X; Tzang CH; Fu L; Yang M; Su YA; Guan XY
Clin Cancer Res; 2008 Aug; 14(16):5061-8. PubMed ID: 18698024
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical detection of ras oncogene p21 product in liver cirrhosis and hepatocellular carcinoma.
Nonomura A; Ohta G; Hayashi M; Izumi R; Watanabe K; Takayanagi N; Mizukami Y; Matsubara F
Am J Gastroenterol; 1987 Jun; 82(6):512-8. PubMed ID: 3034055
[TBL] [Abstract][Full Text] [Related]
33. The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells.
Trerè D; Fiume L; De Giorgi LB; Di Stefano G; Migaldi M; Derenzini M
Br J Cancer; 1999 Oct; 81(3):404-8. PubMed ID: 10507763
[TBL] [Abstract][Full Text] [Related]
34. Expression of vascular endothelial growth factor receptors is closely related to the histological grade of hepatocellular carcinoma.
Amaoka N; Saio M; Nonaka K; Imai H; Tomita H; Sakashita F; Takahashi T; Sugiyama Y; Takami T; Adachi Y
Oncol Rep; 2006 Jul; 16(1):3-10. PubMed ID: 16786116
[TBL] [Abstract][Full Text] [Related]
35. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis.
Lee RG; Tsamandas AC; Demetris AJ
Hepatology; 1997 Dec; 26(6):1415-22. PubMed ID: 9397980
[TBL] [Abstract][Full Text] [Related]
36. Imbalance between cell proliferation and cellular DNA fragmentation in hepatocellular carcinoma.
Wu PC; Lau VK; Fang JW; Lai VC; Lai CL; Lau JY
Liver; 1999 Oct; 19(5):444-51. PubMed ID: 10533805
[TBL] [Abstract][Full Text] [Related]
37. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma.
Wang Z; Zhou J; Fan J; Qiu SJ; Yu Y; Huang XW; Tang ZY
Clin Cancer Res; 2008 Aug; 14(16):5124-30. PubMed ID: 18698030
[TBL] [Abstract][Full Text] [Related]
38. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
[TBL] [Abstract][Full Text] [Related]
39. The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells.
Lampiasi N; Foderà D; D'Alessandro N; Cusimano A; Azzolina A; Tripodo C; Florena AM; Minervini MI; Notarbartolo M; Montalto G; Cervello M
Int J Mol Med; 2006 Feb; 17(2):245-52. PubMed ID: 16391822
[TBL] [Abstract][Full Text] [Related]
40. Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma.
Mi JX; Wang GF; Wang HB; Sun XQ; Ni XY; Zhang XW; Tang JM; Yang DJ
Acta Pharmacol Sin; 2008 Dec; 29(12):1467-77. PubMed ID: 19026166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
